| BA166127 |
1384424-80-9 |
A 1070722 |
GSK-3α and GSK-3β inhibitor; reduces phosphorylation of Tau protein |
|
| BA166475 |
1668553-26-1 |
A 1210477 |
Inhibits anti-apoptotic protein MCL1; antineoplastic |
|
| FA17735 |
78957-85-4 |
A 3 |
Inhibitor of PKA kinase |
|
| BA166576 |
2089148-71-8 |
A 395 |
Inhibitor of polycomb protein EED |
|
| BA166476 |
1889279-16-6 |
A 485 |
Histone acetyltransferase inhibitor of p300/CBP; anti-proliferative |
|
| BA41291 |
1166227-08-2 |
A 66 NEW |
Inhibitor of PI3K kinase; anti-cancer agent; arrhythmogenic |
|
| FA16147 |
844499-71-4 |
A 769662 |
Activates AMP-activated protein kinase (AMPK) |
|
| BA162484 |
909910-43-6 |
A 83-01 |
Inhibitor of TGF-β type I receptor ALK5 kinase |
|
| FA64929 |
959122-11-3 |
A 922500 |
DGAT-1 enzyme antagonist |
|
| BA162794 |
1032229-33-6 |
A 939572 |
Inhibitor of stearoyl-CoA desaturase 1 |
|
| BA166584 |
1037826-77-9 |
A 953227 |
Calpain antagonist |
|
| FA100934 |
934162-61-5 |
A 966492 |
Inhibitor of PARP enzyme |
|
| BA164085 |
1982372-88-2 |
A196 |
Inhibitor of histone-lysine N-methyltransferase SUV420H1 and SUV420H2 |
|
| BE166951 |
945828-50-2 |
AA 29504 |
Allosteric GABAA receptor modulator; anxiolytic |
|
| BF166977 |
1364933-62-9 |
5F-AB 001 |
Synthetic cannabinoid analog |
|
| BM166976 |
895155-25-6 |
AB 005 |
Synthetic cannabinoid |
|
| BA166577 |
1445993-26-9 |
ABBV 075 |
Inhibitor of BET bromodomain; antineoplastic |
|
| BA166477 |
2138861-99-9 |
ABBV 744 |
BET bromodomain inhibitor selective for BDII |
|
| FE103812 |
1231929-97-7 |
Abemaciclib |
Inhibitor of cyclin-dependent kinases CDK4 and CDK6 |
|
| FA159696 |
1231930-82-7 |
Abemaciclib mesylate |
Inhibits cyclin-dependent kinase 4 and 6 (CDK4 and CDK6); antineoplastic |
|
| BA164060 |
154229-19-3 |
Abiraterone |
CYP17 enzyme inhibitor |
|
| BA164133 |
154229-18-2 |
Abiraterone acetate |
CYP17 enzyme inhibitor |
|
| FA126311 |
|
Abiraterone ethyl ether |
CYP17 enzyme inhibitor |
|
| FM61417 |
22972-55-0 |
Abn-CBD |
GPR55 agonist |
|
| FA166721 |
1310726-60-3 |
ABT 494 |
Inhibitor of Janus kinase JAK-1 |
|
| FA16902 |
852808-04-9 |
ABT 737 |
Inhibitor of Bcl-2, Bcl-xl and Bcl-w pro-survival proteins |
|
| FF100506 |
154355-76-7 |
ABT 761 |
Inhibitor of 5-lipoxygenase |
|
| FA16904 |
447407-36-5 |
AC 42 |
Muscarinic (M1) receptor agonist |
|
| FA138815 |
1420477-60-6 |
Acalabrutinib |
Inhibitor of the Bruton tyrosine kinase |
|
| FA101029 |
870281-34-8 |
Acalisib |
Selective PI3Kδ inhibitor |
|
| BA164134 |
77337-73-6 |
Acamprosate calcium |
GABA receptor agonist; threatment for alcohol dependence |
|
| BA17966 |
220556-69-4 |
ACEA |
Cannabinoid (CB1) receptor agonist |
|
| BA164135 |
89796-99-6 |
Aceclofenac |
Cyclooxygenase inhibitor; NSAID |
|
| FA16912 |
53164-05-9 |
Acemetacin |
Non-steroidal anti-inflammatory drug |
|
| FA158666 |
59-53-0 |
N-Acetyl-DL-penicillamine |
Protective agent against mercuric chloride poisoning |
|
| BA166874 |
51037-30-0 |
Acipimox |
Niacin receptor 1 (NIACR1) antagonist; lipid lowering |
|
| BA164136 |
55079-83-9 |
Acitretin |
Retinoid;activates nuclear retinoid acid receptor; antineoplastic; anti-psoratic |
|
| FA31012 |
320345-99-1 |
Aclidinium bromide |
Muscarinic antagonist; bronchodilator |
|
| BA17967 |
229021-64-1 |
ACPA |
CB1 cannabinoid receptor agonist |
|
| FA17211 |
18699-02-0 |
Actarit |
Inhibitor of IL-1 secretion; anti-inflammatory; immunomodulatory |
|
| BA164806 |
1316214-52-4 |
ACY 1215 |
Inhibitor of histone deacetylase 6 |
|
| FI139131 |
331731-18-1 |
Adalimumab |
Monoclonal antibody against TNFα; therapy for rheumatoid arthritis |
|
| BA164138 |
106685-40-9 |
Adapalene |
Agonist of retinoic acid receptors (RAR-β and RAR-γ); pro-apoptotic |
|
| BA164139 |
142340-99-6 |
Adefovir dipivoxil |
Anti-viral; reverse transcriptase inhibitor |
|
| FA17224 |
791828-58-5 |
Aderbasib |
Dual inhibitor of ADAM10 and ADAM17 metalloproteases |
|
| FA103122 |
851881-60-2 |
ADX 47273 |
Positive allosteric modulator of mGlu5 receptors |
|
| BA166488 |
851881-59-9 |
(R)-ADX 47273 |
Inhibits metabotropic glutamate receptor (mGluR5) |
|
| FA17229 |
497839-62-0 |
AEE 788 |
Dual inhibitor of EGFR and VEGR receptor phosphorylation; anti-metastatic |
|
| BA165790 |
865305-30-2 |
AF 353 |
Antagonist of P2X3/P2X2/3 purinoreceptors |
|
| BA164141 |
850140-72-6 |
Afatinib |
Irreversible inhibitor of ErbB1, ErbB2/HER2 and ErbB4 receptor tyrosine kinases |
|